Private & confidential
Dr. Zhang Huayan
Chinese name: 张华岩
Chief Physician, Professor . Neonatology
Dr. Zhang Huayan is Director of the Neonatal Medical Center at Guangzhou Women and Children's Medical Center and a professor at Guangzhou Medical University. Also an attending neonatologist at the Children's Hospital of Philadelphia, she is an internationally recognized expert in neonatal respiratory support and bronchopulmonary dysplasia.

Dr. Zhang Huayan
Neonatal centre leadership
Clinical experience in paediatric surgery
NICU beds at the Guangzhou centre
since 2018
2024 Fok Ying Tung World Outstanding Chinese Physician Award
200 3. International honour
About Dr. Zhang Huayan
Dr. Zhang Huayan is Director of the Neonatal Medical Center at Guangzhou Women and Children's Medical Center and a professor at Guangzhou Medical University. She also serves as an attending neonatologist at the Children's Hospital of Philadelphia and a clinical professor at the University of Pennsylvania Perelman School of Medicine. Her clinical and research work focuses on neonatal respiratory support, prevention of lung injury and the management of bronchopulmonary dysplasia, and she received the Children's Hospital of Philadelphia Top Paediatrician Award in 2018.

1、Director of the Neonatal Medical Center at Guangzhou Women and Children’s Medical Center
2、Professor at Guangzhou Medical University and attending neonatologist at the Children’s Hospital of Philadelphia
3、Clinical Professor at the University of Pennsylvania Perelman School of Medicine
4、Vice President of the Pediatric Branch of the World Association of Chinese Doctors
5、Vice Chairman of the Pediatric Critical Care Physicians Branch of the Chinese Medical Doctor Association
6、Recipient of the Children’s Hospital of Philadelphia Top Paediatrician Award in 2018
Dr. Zhang Huayan ’s Three Key Areas of Expertise
Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.
Critical neonatal care
She leads the care of critically ill newborns, including extremely and very low birth weight infants, providing advanced respiratory support, nutritional management and close monitoring to stabilise fragile babies and support healthy growth and long-term development after intensive care and during long-term follow-up.
Neonatal respiratory support
She is a world-recognized authority on mechanical ventilation and non-invasive respiratory support for newborns, tailoring strategies to protect the immature lung and prevent injury in preterm infants who require prolonged breathing support, careful long-term follow-up and monitoring of lung development.
Bronchopulmonary dysplasia
She specialises in the prevention and treatment of bronchopulmonary dysplasia, a chronic lung disease of prematurity, using individualized ventilation, nutrition and multidisciplinary care to improve lung function and long-term respiratory outcomes in very preterm infants and support their development across childhood.
More: neonatal ECMO——extracorporeal support; extreme prematurity——intensive care; neonatal hyperbilirubinemia——management; chronic lung disease——follow-up; neonatal training——education
Selected cases, research & publications
Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Respiratory Support Strategies for Bronchopulmonary Dysplasia
This editorial reviews respiratory support for infants with bronchopulmonary dysplasia, the chronic lung disease of prematurity, discussing non-invasive ventilation, volume-targeted modes and weaning approaches. It guides neonatologists in choosing lung-protective strategies that reduce ventilator-induced injury and improve outcomes for very preterm infants with severe bronchopulmonary dysplasia.
2. Intrinsic Positive End-Expiratory Pressure in Severe Bronchopulmonary Dysplasia
A retrospective study of infants with severe bronchopulmonary dysplasia measured intrinsic positive end-expiratory pressure during mechanical ventilation. Very high values were associated with ineffective triggering, patient-ventilator dyssynchrony and worse outcomes, including failure to wean and death, highlighting the importance of bedside assessment in these fragile preterm infants.
3. Clinical Cohort Study of Bronchopulmonary Dysplasia Prevention
This registered clinical study follows preterm infants in a prospective cohort to identify early predictors of bronchopulmonary dysplasia and to evaluate prevention strategies. Results aim to refine respiratory management in neonatal intensive care and reduce chronic lung disease in very low birth weight infants needing prolonged oxygen and ventilator support.
Related link: https://clinicaltrials.gov/study/NCT06341582
4. Non-Invasive Bilirubin Monitoring and Phototherapy in Newborns
This 2025 study examined non-invasive measurement of bilirubin and the use of phototherapy for neonatal jaundice, comparing monitoring approaches with treatment thresholds. It supports safer, less painful assessment and timely treatment of hyperbilirubinaemia, helping prevent kernicterus and severe jaundice in newborns, including those born prematurely.
Related link: https://doi.org/10.1186/s12887-025-06073-x
5. National Neonatal Network Collaboration and Quality Improvement
This report describes a national clinical network of neonatal intensive care units collaborating on registry data and quality improvement for very preterm infants. It documents centres and investigators working to standardise care, compare outcomes and reduce complications such as bronchopulmonary dysplasia, intraventricular haemorrhage and necrotising enterocolitis across China.
Related link: https://pm.amegroups.org/article/view/6964/html
6. World Outstanding Chinese Physician Award 2024
This news report announces that a senior neonatologist was honoured with the 2024 Fok Ying Tung World Outstanding Chinese Physician Award for contributions to newborn medicine. It notes leadership of a national key neonatal department, clinical work on severe bronchopulmonary dysplasia and efforts to advance neonatal intensive care in China.
Related link: https://www.gzfezx.com/news/show/9511.html
Where Dr. Zhang Huayan practices

Guangzhou Women and Children’s Medical Center
Chinese name: 广州医科大学附属妇女儿童医疗中心
Guangzhou Women and Children's Medical Center, South China's largest public women's and children's tertiary hospital since its founding in 2006, is the national children's regional medical center holding 8 national key specialties, 2,400 beds, JCI accreditation and the top A national performance grade.
Since 2006
20 years of women & child care
2,400
Licensed beds
4.89 million (2025)
Annual outpatient visits
Since 2012
Licensed beds
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
Why patients travel to China for treatment
Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.
Clinical capability at international standard
Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.
Diagnostics and treatment in days, not months
A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.
Transparent, itemised pricing
Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.
Policy channels that open the door
China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
Consulting this physician, step by step
From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
- Share your storyA private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
- Records review & matchingOrisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
- Your consultationAppointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
- Reports & follow-upTranslated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Zhang Huayan?
Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Information Sources
This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.
- Guangzhou Women and Children’s Medical Center Official Expert Page: https://www.gzfezx.com/doctor/show/18.html
- PubMed Author Records (neonatal respiratory support and bronchopulmonary dysplasia): https://pubmed.ncbi.nlm.nih.gov/39467671/
Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.
Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Zhang Huayan.